Factor V inhibitor in neonatal intracranial hemorrhage secondary to severe congenital factor V deficiency

American Journal of Pediatric Hematology/Oncology

Volumn 23, Issue 4, 2001, Pages 244-246

  Lee, Way Seah ^a   Chong, Lee Ai ^a   Begum, Sabeera ^a   Abdullah, Wan Ariffin ^a   Koh, Mia Tuang ^a   Lim, Ee Jin ^a  

^a UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

Congenital factor V deficiency; Factor V inhibitor; Intracranial hemorrhage; Newborn infant

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; CYCLOPHOSPHAMIDE; FRESH FROZEN PLASMA; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ARTICLE; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BLOOD CLOTTING FACTOR DEFICIENCY; BRAIN HEMORRHAGE; CASE REPORT; EXCHANGE BLOOD TRANSFUSION; FEMALE; HUMAN; HYDROCEPHALUS; IMMUNOSUPPRESSIVE TREATMENT; INFANT; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME;

BRACHIAL ARTERY; CEREBRAL HEMORRHAGE; COMBINED MODALITY THERAPY; CONSANGUINITY; CYCLOPHOSPHAMIDE; EXCHANGE TRANSFUSION, WHOLE BLOOD; FACTOR V; FACTOR V DEFICIENCY; FATAL OUTCOME; FEMALE; HUMANS; HYDROCEPHALUS; IMMUNIZATION; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; INFANT, NEWBORN; ISOANTIBODIES; PLASMA; PLATELET TRANSFUSION; PREDNISOLONE; RECURRENCE; THROMBOSIS; VENTRICULOPERITONEAL SHUNT;

EID: 0035003643     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200105000-00013     Document Type: Article

References (14)

1. Seeler RA. Parahaemophilia: factor V deficiency. Med Clin North Am 1972; 56:119-25.
2. th ed. New York: United States, 1995.
3. Totan M, Albayrak D. Intracranial haemorrhage due to factor V deficiency. Acta Paediatr 1999; 88:342-3.
4. Fratantoni JC, Hilgartner M, Nachman RL. Nature of the defect in congenital factor V deficiency: study in a patient with an acquired circulating anticoagulant. Blood 1972; 39:751-8.
5. Mazzucconi MG, Solinas S, Chistolini A, et al. Inhibitor of factor V in severe congenital factor V deficiency: a case report. Nouvelle Revue Francaise Hematol 1985; 27:303-5.
6. Knobl P, Lechner K. Acquired factor V inhibitor. Baillieres Clin Hematol 1998; 11:305-18.
7. Tarantino MD, Ross MP, Daniels TM, et al. Modulation of an acquired coagulation factor V inhibitor with intravenous immune globulin. J Pediatr Clin Hematol Oncol 1997, 19:226-31.
8. Muntean W, Zenz W, Finding K, et al. Inhibitor to factor V after exposure to fibrin sealant during cardiac surgery in a two-year-old child. Acta Paediatr 1994; 83:84-7.
9. Shapiro SS. Antibodies to blood coagulation factors. Clin Haematol 1979; 8:207-14.
10. Chediak J, Ashenhurst JB, Garlick I, et al. Successful management of bleeding in a patient with factor V inhibitor by platelet transfusion. Blood 1980; 56:835-41.
11. Vickars LM, Coupland RW, Naiman SC. The response of an acquired factor V inhibitor to activated factor IX concentrate. Transfusion 1985; 25:51-3.
12. Grupp BA, Bove KE, Donaldson VH. Fatal myocardial necrosis associated with prothrombin-complex-concentrate therapy in hemophilia A. N Engl J Med 1983; 309:242-3.
13. Manotti C, Quintavalla R, Pini M. Thromboembolic manifestations and congenital factor V deficiency: a family study. Haemostasis 1989; 19:331-9.
14. Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990; 12:95-104.